Aijaz Ahmed
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Gastroenterology & Hepatology
Contact Information
-
Clinical Offices
Liver Transplant Clinic 300 Pasteur Dr A160 MC 5309 Stanford, CA 94305-2200 Tel Work (650) 723-6961 Fax (650) 725-8418Hepatology Clinic 300 Pasteur Dr A160 MC 5303 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
- Academic Offices
Administrative Contact Aijaz Ahmed Associate Professor of Medicine Email Tel Work 650-498-6091Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Gastroenterology
- Hepatology (Liver)
- Liver Transplantation
Professional Education
| Board Certification: | Gastroenterology, American Board of Internal Medicine (2000) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1999) |
| Residency: | Brown University Program, RI (1996) |
| Internship: | University of Minnesota School of Medicine, MN (1993) |
| Internship: | New York Medical College, NY (1992) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Bristol-Myers-Squibb , Gilead Sciences, Inc. , Schering-Plough Corporation , Thre Rivers Pharmaceuticals |
Scientific Focus
Clinical Trials
Publications
- Management of biliary strictures following liver transplantation. Dig Dis Sci. 2009; (1): 25-7
- Prevalence of colorectal neoplasms in Asian Americans. Dig Dis Sci. 2009; (1): 160-7
- Adenovirus-induced acute liver failure. Dig Dis Sci. 2009; (2): 218-21
- Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis. 2009; (9): 1275-85
- Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant. 2009; (5): 1158-68
Help
ITI Internal